KORU Medical Systems, Inc. announced its financial results for Q3 2023 and updated full year financial outlook, appointed Kenneth Miller as Chief Commercial Officer, and received FDA clearance for use of the FREEDOM60 Infusion System with Hizentra 50 mL prefilled syringes.